Angioplasty and/or stenting after thrombectomy in patients with large vessel occlusion associated with underlying intracranial atherosclerotic stenosis: a meta-analysis and systematic review - Report - MDSpire

Angioplasty and/or stenting after thrombectomy in patients with large vessel occlusion associated with underlying intracranial atherosclerotic stenosis: a meta-analysis and systematic review

  • By

  • Hesham Kelani

  • Hazem Mohamed Salamah

  • Eli Berglas

  • Emina Dzafic

  • Shivasuryan Vummidi

  • Huzaifa Dorria

  • Emily Wen Jing Shuai

  • Gitanjali Reddy

  • Desen Zeng

  • Ariel Makower

  • Dylan Davie

  • Amber Khemlani

  • Diana Greene-Chandos

  • Volodymyr Vulkanov

  • David Rosenbaum-HaLevi

  • David P. Lerner

  • Lisa R. Merlin

  • Priyank Khandelwal

  • October 16, 2025

  • 0 min

Share

Meta-Analysis of Angioplasty and Stenting After Thrombectomy in ICAS-LVO Stroke

Overview

This systematic review and meta-analysis evaluated the efficacy and safety of mechanical thrombectomy combined with angioplasty and/or stenting (MT + angioplasty/stent) versus mechanical thrombectomy (MT) alone in patients with large vessel occlusion due to intracranial atherosclerotic stenosis (ICAS-LVO). The analysis included both randomized controlled trials and observational studies, focusing on vessel recanalization, functional independence, and safety outcomes.

Background

Ischemic stroke is a major cause of morbidity and mortality worldwide, with large vessel occlusion (LVO) accounting for approximately 20% of ischemic strokes and associated with worse outcomes. Intracranial atherosclerotic stenosis (ICAS) is a significant cause of LVO, with variable prevalence depending on population characteristics. Mechanical thrombectomy (MT) is the standard treatment for ICAS-LVO, but the presence of ICAS increases the risk of reocclusion and recurrent stroke. Given these challenges, adjunctive angioplasty and/or stenting following MT has been explored to improve vessel patency and clinical outcomes.

Data Highlights

OutcomeMT + Angioplasty/StentMT AloneRisk Ratio (95% CI)
Vessel RecanalizationHigher rates reportedLower rates reportedSignificant improvement with MT + angioplasty/stent
Functional Independence (mRS 0–2 at 90 days)Improved functional outcomesLower functional independenceFavorable for MT + angioplasty/stent
Symptomatic Intracranial HemorrhageNo significant increaseComparable ratesNo significant difference
Mortality at 90 daysSimilar or reduced mortalityComparable mortalityNo significant difference

Key Findings

  • MT combined with angioplasty and/or stenting significantly improves vessel recanalization rates compared to MT alone in ICAS-LVO patients.
  • Functional independence at 90 days (mRS 0–2) is higher in patients treated with MT + angioplasty/stent.
  • No significant increase in symptomatic intracranial hemorrhage was observed with adjunctive angioplasty/stenting.
  • Mortality rates at 90 days did not differ significantly between treatment groups.
  • Subgroup analyses suggest benefits are consistent in patients with stenosis >70%.

Clinical Implications

For patients with ICAS-related large vessel occlusion stroke, adjunctive angioplasty and/or stenting following mechanical thrombectomy may enhance vessel recanalization and improve functional outcomes without increasing hemorrhagic complications. Clinicians should consider vessel-directed therapies in selected patients, especially those with significant stenosis, to reduce the risk of reocclusion and recurrent stroke.

Conclusion

Mechanical thrombectomy combined with angioplasty and/or stenting appears to be a safe and effective strategy to improve recanalization and functional outcomes in ICAS-LVO stroke patients. Further randomized controlled trials are warranted to confirm these findings and optimize treatment protocols.

References

  1. PRISMA Guidelines 2020 -- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
  2. Newcastle–Ottawa Scale 2011 -- Quality Assessment Tool for Observational Studies
  3. PROSPERO Registration CRD420251010571 -- Systematic Review Protocol

Original Source(s)

Related Content